Barclays’s LifePoint Health, Inc. LPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,100
| Closed | -$71K | – | 7818 |
|
|
2018
Q3 | $71K | Buy |
1,100
+900
| +450% | +$54.8K | ﹤0.01% | 5842 |
|
|
2018
Q2 | $10K | Sell |
200
-3,200
| -94% | -$166K | ﹤0.01% | 6560 |
|
|
2018
Q1 | $160K | Sell |
3,400
-600
| -15% | -$28.9K | ﹤0.01% | 5021 |
|
|
2017
Q4 | $199K | Buy |
4,000
+3,100
| +344% | +$154K | ﹤0.01% | 4696 |
|
|
2017
Q3 | $52K | Buy |
900
+700
| +350% | +$41.6K | ﹤0.01% | 5338 |
|
|
2017
Q2 | $13K | Sell |
200
-100
| -33% | -$6.32K | ﹤0.01% | 5981 |
|
|
2017
Q1 | $20K | Sell |
300
-49,800
| -99% | -$3.08M | ﹤0.01% | 5824 |
|
|
2016
Q4 | $2.85M | Buy |
50,100
+47,900
| +2,177% | +$2.77M | ﹤0.01% | 1833 |
|
|
2016
Q3 | $130K | Buy |
2,200
+200
| +10% | +$12K | ﹤0.01% | 4319 |
|
|
2016
Q2 | $131K | Buy |
+2,000
| New | +$136K | ﹤0.01% | 4221 |
|
|
2015
Q4 | – | Sell |
-3,400
| Closed | -$238K | – | 7291 |
|
|
2015
Q3 | $238K | Buy |
3,400
+300
| +10% | +$24.3K | ﹤0.01% | 4011 |
|
|
2015
Q2 | $267K | Buy |
+3,100
| New | +$234K | ﹤0.01% | 3950 |
|
|
2015
Q1 | – | Sell |
-800
| Closed | -$57K | – | 7596 |
|
|
2014
Q4 | $57K | Hold |
800
| – | – | ﹤0.01% | 5623 |
|
|
2014
Q3 | $55K | Sell |
800
-100
| -11% | -$7.03K | ﹤0.01% | 5814 |
|
|
2014
Q2 | $55K | Buy |
900
+600
| +200% | +$35.2K | ﹤0.01% | 5867 |
|
|
2014
Q1 | $16K | Sell |
300
-800
| -73% | -$42.8K | ﹤0.01% | 6727 |
|
|
2013
Q4 | $57K | Sell |
1,100
-18,900
| -95% | -$949K | ﹤0.01% | 6096 |
|
|
2013
Q3 | $920K | Buy |
+20,000
| New | +$958K | ﹤0.01% | 3443 |
|
Other funds holding LPNT
Barclays's LPNT Position: Q4 2018 in Review
Barclays sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 118,891 shares — an estimated $7.66M sold.
Barclays first reported a position in LPNT in Q2 2013 and held it in 22 quarters. The position peaked at $7.66M in Q3 2018. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.
- Barclays reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
- Barclays sold 118,891 LifePoint Health, Inc. shares in Q4 2018, an estimated $7.66M.
- Barclays first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 22 quarters.
- Barclays's LifePoint Health, Inc. position peaked at $7.66M in Q3 2018.
- 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.
Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.